Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2.21 million versus the consensus estimate of $2.5 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.